View Author
study patient genotype metformin effect level polymorphism therapy rotterdam study difference simvastatin participant cholesterol medication number transporter prescription rotterdam result sulfonylurea allele pharmacy variation association diabetes interaction mortality measurement hba 1c level change response glucose table metformin therapy chapter nos 1ap gene abcb 1 gene gg genotype diabetes mellitus calcium period pharmacol channel variant reduction cyp 2c mellitu hba 1c measurement admission outcome incident haplotype hospital population drug reactions drug response analysis atorvastatin levodopa medication administration errors reaction cyp 3a slc 22a gene patient outcomes incident metformin users slc 47a gene tolbutamide determinant error cohort oct 1 cation group cyp 2c genotype glibenclamide health drug-drug interactions disease tt genotype enzyme
10 Most Recent Publications
|
SMC6 is an essential gene in mice, but a hypomorphic mutant in the ATPase domain has a mild phenotype with a range of subtle abnormalities
(Article)
Ju, L. Wing, J. Adler, T. Becker, J. Rozman, J. Klingenspor, M. Hanssen-de Wolf, J.E. Zimmer, A. Klopstock, T. Busch, D.H. Gailus-Durner, V. Fuchs, H. Taylor, M.E. Angelis, M.H. de Horst, G.T.J. van der Lehmann, A.R. Brandt, R.M.C. Slijepcevic, P. Horsch, M. Rathkolb, B. Rácz, I. Becker, M.L. Bijlsma, J.W.J. |
2013-03-19
|
|
Research highlights
(Article)
Keyser, C.E. de Stricker, B.H.Ch. Becker, M.L. |
2012-01-01
|
|
Novel CYP3A4 intron 6 single nucleotide polymorphism is associated with simvastatin-mediated cholesterol reduction in the Rotterdam Study
(Article)
Elens, L. Becker, M.L. Haufroid, V. Hofman, A. Visser, L.E. Uitterlinden, A.G. Stricker, B.H.Ch. Schaik, R.H.N. van |
2011-12-01
|
|
The impact of type of manual medication cart filling method on the frequency of medication administration errors: A prospective before and after study
(Article)
Schimmel, A.M. Becker, M.L. Bout, T. van den Taxis, K. Bemt, P.M.L.A. van den |
2011-07-01
|
|
OCT1 polymorphism is associated with response and survival time in anti-Parkinsonian drug users
(Article)
Becker, M.L. Visser, L.E. Schaik, R.H.N. van Hofman, A. Uitterlinden, A.G. Stricker, B.H.Ch. |
2011-02-01
|
|
Influence of genetic variation in CYP3A4 and ABCB1 on dose decrease or switching during simvastatin and atorvastatin therapy
(Article)
Becker, M.L. Visser, L.E. Schaik, R.H.N. van Hofman, A. Uitterlinden, A.G. Stricker, B.H.Ch. |
2010-01-01
|
|
Interaction between polymorphisms in the OCT1 and MATE1 transporter and metformin response
(Article)
Becker, M.L. Visser, L.E. Schaik, R.H.N. van Hofman, A. Uitterlinden, A.G. Stricker, B.H.Ch. |
2010-01-01
|
|
Common genetic variation in the ABCB1 gene is associated with the cholesterol-lowering effect of simvastatin in males
(Article)
Becker, M.L. Visser, L.E. Schaik, R.H.N. van Hofman, A. Uitterlinden, A.G. Stricker, B.H.Ch. |
2009-12-02
|
|
Individualizing Pharmacotherapy: Genetic factors and co-prescribed drugs affecting pharmacotherapy
(Doctoral Thesis)
Becker, M.L. |
2009-11-04
|
|
Genetic variation in the multidrug and toxin extrusion 1 transporter protein influences the glucose-lowering effect of metformin in patients with diabetes: A preliminary study
(Article)
Becker, M.L. Visser, L.E. Schaik, R.H.N. van Hofman, A. Uitterlinden, A.G. Stricker, B.H.Ch. |
2009-03-01
|